Sana Biotechnology, Inc.
SANA
$4.13
$0.163.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -234.41M | -252.18M | -208.67M | -266.76M | -305.81M |
| Total Depreciation and Amortization | 13.50M | 14.37M | 15.40M | 15.50M | 15.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.82M | 67.38M | -8.33M | 29.29M | 57.12M |
| Change in Net Operating Assets | -9.26M | -10.30M | -4.58M | -1.19M | 4.79M |
| Cash from Operations | -158.35M | -180.74M | -206.18M | -223.15M | -227.95M |
| Capital Expenditure | -501.00K | -4.55M | -17.72M | -33.43M | -47.04M |
| Sale of Property, Plant, and Equipment | 771.00K | 635.00K | 253.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.08M | 117.06M | 128.75M | 50.88M | 32.72M |
| Cash from Investing | 23.35M | 113.15M | 111.28M | 17.45M | -14.33M |
| Total Debt Issued | -56.00K | 116.00K | 7.74M | 7.74M | 7.80M |
| Total Debt Repaid | -258.00K | -171.00K | -85.00K | -- | -- |
| Issuance of Common Stock | 112.04M | 4.32M | 6.74M | 192.01M | 193.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -60.00K | -- | -- |
| Cash from Financing | 111.73M | 4.27M | 14.33M | 199.75M | 200.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.28M | -63.32M | -80.56M | -5.95M | -41.45M |